Fibroblast Growth Factor Receptor 2: Expression, Roles, and Potential As a Novel Molecular Target for Colorectal Cancer
Open Access
- 4 June 2012
- journal article
- review article
- Published by Hindawi Limited in Pathology Research International
- Vol. 2012, 1-8
- https://doi.org/10.1155/2012/574768
Abstract
The fibroblast growth factor receptor (FGFR) family consists of four members, named FGFR1, 2, 3, and 4. All 4 FGFRs and their ligands, fibroblast growth factors (FGFs), are expressed in colorectal cancer (CRC). Recent studies have shown that FGFR2 plays important roles in cancer progression; therefore, it is of great interest as a novel target for cancers. Expression of FGFR2 regulates migration, invasion, and growth in CRC. Expression of the FGFR2 isoform FGFR2 IIIb was associated with well-differentiated histological types, and its specific ligand, FGF7, enhanced angiogenesis and adhesion to type-IV collagen via FGFR2 IIIb in CRC. FGFR2 IIIc is detected in CRC, but its roles have not been well elucidated. Interactions between FGFR2 IIIb and IIIc and FGFs may play important roles in CRC via autocrine and/or paracrine signaling. Several kinds of molecular-targeting agents against FGFR2 have been developed; however, it is not clear how a cancer treatment can most effectively inhibit FGFR2 IIIb or FGFR2 IIIc, or both isoforms. The aim of this paper is to summarize the roles of FGFR2 and its isoforms in CRC and clarify whether they are potent therapeutic targets for CRC.Keywords
This publication has 79 references indexed in Scilit:
- Enhanced Expression of Fibroblast Growth Factor Receptor 2 IIIc Promotes Human Pancreatic Cancer Cell ProliferationThe American Journal of Pathology, 2012
- Fibroblast growth factor receptor 3-IIIc mediates colorectal cancer growth and migrationBritish Journal of Cancer, 2010
- Treatment in advanced colorectal cancer: what, when and how?British Journal of Cancer, 2009
- ESRP1 and ESRP2 Are Epithelial Cell-Type-Specific Regulators of FGFR2 SplicingMolecular Cell, 2009
- Novel breast cancer risk alleles and endometrial cancer riskInternational Journal of Cancer, 2008
- FGF10/FGFR2 signal induces cell migration and invasion in pancreatic cancerBritish Journal of Cancer, 2008
- Genome-wide association study identifies novel breast cancer susceptibility lociNature, 2007
- A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancerNature Genetics, 2007
- Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromesOncogene, 2007
- Alternative inclusion of fibroblast growth factor receptor 2 exon IIIc in Dunning prostate tumors reveals unexpected epithelial mesenchymal plasticityProceedings of the National Academy of Sciences of the United States of America, 2006